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Abstract
Esophageal conduit ischaemia and necrosis is an uncommon but devastating
complication of esophagectomy and remains one of the most challenging issues
in surgical practice. The incidence, time interval to develop symptoms, and
clinical presentation are highly variable with no predictable pattern. Evidence
comes from case reports and case series rather than randomized controlled trials.
We describe the issues surrounding conduit necrosis affecting the stomach,
jejunum and colon as an esophageal replacement and the advantages,
disadvantages and challenges of each type of reconstruction. Diagnosis is
challenging for the most experienced surgeon. Upper gastrointestinal endoscopy
and computed tomography thorax with both oral and intravenous contrast is the
gold standard. Management, either conservative or interventional is also a
difficult decision. Management options include conservative treatment and more
aggressive treatments such as stent insertion, surgical debridement and repair of
the esophagus using jejunum, colon or a musculocutaneous flap. In spite of recent
advances in surgical techniques, there is no reliable strategy to manage
esophageal conduit necrosis. Our review covers the pathophysiology and clinical
significance of esophageal necrosis while highlighting current techniques of
prevention, diagnosis and treatment of this life-threatening condition.
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Core tip: Esophageal conduit necrosis is an uncommon but devastating complication of
esophagectomy and remains one of the most challenging issues in surgical practice. The
purpose of this literature review is to provide the practicing surgeon with an up to date
literature review on this complication and discuss the management of this rare condition.
The incidence, time interval to develop symptoms, and clinical presentation are highly
variable with no predictable pattern. Evidence comes from case reports and case series
rather than randomized controlled trials. Our review details the pathophysiology,
predisposing factors, clinical symptoms, diagnostic approach and we will highlight
treatment options for the management of this life threatening condition.
Citation: Athanasiou A, Hennessy M, Spartalis E, Tan BHL, Griffiths EA. Conduit necrosis
following esophagectomy: An up-to-date literature review. World J Gastrointest Surg 2019;
11(3): 155-168
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INTRODUCTION
Esophageal cancer is one of the most common causes of cancer related mortality and
morbidity worldwide[1].  Despite improvements in the standardisation of surgical
techniques, better case selection of patients for surgery, preoperative optimisation of
nutritional status and improved intensive care unit (ICU) care, esophagectomy is still
associated with significant rate of post-operative complications[2]. The anastomosis
between the oesophagus and the replacement conduit is challenging, with a wide
variety of different surgical techniques proposed in the literature. The four main
complications affecting the oesophagogastric anastomosis and the gastric conduit
after  the  creation  of  neo-esophagus  are  anastomotic  leak,  anastomotic  stricture,
conduit ischemia and conduit necrosis[3]. Gastric conduit necrosis is the severest of
these complications and is considered to be life threatening with a high mortality
rate[3,4]. This is due to the development of widespread mediastinal sepsis, and as a
result, conservative treatment is generally contraindicated. Upper gastrointestinal (GI)
endoscopy is considered to be the gold standard for the diagnosis and differentiates
between conduit  necrosis and conduit  ischemia[5].  Patients with conduit  necrosis
require urgent fluid resuscitation, broad spectrum antibiotic and anti-fungal coverage,
early surgical exploration with drainage of all infected collections and debridement of
the necrotic  conduit  and esophageal  diversion proximally[6].  The purpose of  this
literature review is to provide the practising surgeon with an up to date literature
review  on  this  devastating  complication.  As  such  we  have  performed  a
contemporaneous systematic review and will describe and discuss the incidence of
this rare complication, clinical manifestations, diagnostic strategy and management
options available to help esophageal surgeons deal with this situation.
Definition
Esophageal  conduit  necrosis  is  death  or  ischaemia  of  the  conduit  used  in  the
construction of the neo-esophagus, which is typically stomach, but can also occur
when using the jejunum or colon for esophageal replacement. The distinction between
conduit  necrosis  and  conduit  ischemia  is  crucial  as  the  treatment  approach  is
different.  Fortunately,  ischaemia  does  not  always  lead  to  conduit  necrosis  or
anastomotic breakdown and healing can occur. The clinical range of gastric conduit
ischaemia is broad and includes subclinical cases that resolve without intervention,
ischemic-related anastomotic leak or stricture formation, and frank stomach necrosis.
In addition, conduit ischemia may or may not be associated with anastomotic leakage.
Veeramootoo  et  al [ 7 ]  in  2009  categorised  gastric  conduit  necrosis  after
esophagectomy  to  the  following  three  types:  Type  I  is  consider  to  be  Simple
“anastomotic leak” without significant intramucosal necrosis. Type II is focal necrosis
at the conduit tip which requires resection and refashioning of the esophago-gastric
anastomosis.Type III is more extensive necrosis of the conduit requiring resection and
delayed reconstruction.
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Prior to 2015, there was a lack of standardization and the absence of generally
accepted definitions  of  complications  in  esophageal  surgery  and this  hampered
outcome assessment after esophagectomy and made comparisons between studies
very difficult. However, in 2015, 21 international esophageal surgeons collaborated to
produce  the  Esophageal  Complications  Consensus  Group (ECCG) guidelines  to
standardise all complications and adverse events occurring during in-hospital stay
after  esophagectomy,  such  as  anastomotic  leak,  chyle  leak,  delayed  gastric
emptying[8].  Table  1  shows the  consensus  of  definition  for  conduit  necrosis  and
conduit ischemia[8].  Type 1 is focal conduit ischaemia which does not require any
treatment, but requires close endoscopic monitoring to ensure it resolves and does not
progress to frank full thickness conduit necrosis. In this scenario is often mucosa
ischaemia rather than full  thickness ischaemia. Type 2 is more extensive conduit
ischaemia, without associated anastomotic leakage, which requires treatment with
surgery (this usually results in resection of the ischaemic area and reformation of the
anastomosis).  Type  3  conduit  necrosis  is  a  completely  necrotic  stomach  which
requires resection, esophageal diversion with a cervical oesophagostomy and enteral
feeding access. In Type 3 conduit necrosis, delayed reconstruction if no metastases
develops in the interval period is the procedure of choice. However, certain patients
are  not  suitable  for  reconstruction due to  inadequate  fitness  to  undergo further
surgery, early recurrence or patient choice to avoid an even more complex procedure.
There is obviously some overlap between anastomotic leakage and conduit ischaemia
and necrosis according to this classifications.
Clinical manifestations
The most  common clinical  manifestations of  conduit  ischaemia and necrosis  are
tachycardia,  tachypnoea,  fever and altered mental  status.  There is  much overlap
between patients presenting with gastric conduit ischaemia/necrosis and those of an
anastomotic leak. Clinical suspicion, early diagnosis and expeditious management are
vital to reduce morbidity and mortality. Severe sepsis or septic shock is late signs.
Signs can include saliva or GI contents exuding from the neck incision or bile within
the chest drain[3]. Worrying signs of potential gastric conduit necrosis include bloody
or feculent nasogastric output, lactic acidosis or haemodynamically unitability such as
hypotension  and  shock.  In  some  patients  a  foul  odour  or  “bad  breath”  can  be
apparent  at  the  bedside  and  is  caused  by  necrosis  of  the  conduit  and  bacterial
overgrowth in the necrotic tissue.
Diagnosis
Some surgeons routinely arrange a water soluble swallow prior to commencing oral
intake,  but  this  has  some disadvantages,  including the  risks  of  aspiration,  false
negative results and the risk that anastomotic or conduit complications occur before
the timing of the investigation[9,10]. Whilst a water soluble (gastrograffin) swallow is
helpful for patients with a high predicted probability of an anastomotic leak who are
alert and able to sit up for the investigation, it can be largely normal even in advanced
conduit ischaemia. This is because the contrast remains within the gastric lumen and
not be associated with an anastomosis leak in some situations[9]. In addition, contrast
swallows are not appropriate for patients who are intubated and ventilated on ICU. In
this scenario bedside endoscopy on the ICU, preferably performed by the operating
surgeon  is  a  better  test  of  the  viability  of  the  gastric  conduit  and  whether  an
anastomotic leak is present[11]. It is for this reason that upper GI endoscopy and CT
thorax with intravenous contrast (IV) and oral contrast are considered to be the “gold
standard’’ for the diagnosis of conduit necrosis and anastomotic leakage.
Clear radiological evidence of anastomotic leak are more specific than the findings
of  conduit  necrosis.  However,  CT  is  crucial  for  the  detection  of  intrathoracic
collections which need to be drained. CT findings include gastric and esophageal wall
thickening  with  possible  small  gas  bubbles  in  soft  tissues,  especially  at  the
anastomotic level[12]. Furthermore, CT sensitivity for detection of free extra-luminal
contrast and mediastinal collections and contamination is high. Nonetheless, it has
been observed that some patients with partial or non-full thickness gastric conduit
ischemia can have a normal CT scan[12].
Routine Upper GI endoscopy within one week following esophagectomy has been
proposed in the literature for the evaluation of gastric conduit and the integrity of the
anastomosis[13,14]. Page et al[14], assessed the efficacy and safety of upper GI endoscopy
in 100 patients within one week after  esophagectomy. Their  results  showed that
endoscopy is very safe and accurate method for the diagnosis of conduit ischaemia
and necrosis and allows more individualized patient management. Tom DeMeester’s
group has published an endoscopic classification system for the findings of gastric
conduit ischaemia and necrosis (Table 2)[12].
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Table 1  The Esophageal Complications Consensus Group definition and classification of conduit necrosis and ischemia[8]
Type Diagnosis Treatment
Type I: Conduit necrosis focal Identified endoscopically Additional monitoring or non-surgical therapy
Type II: Conduit necrosis focal Identified endoscopically and not associated with
free anastomotic or conduit leak
Surgical therapy not involving esophageal
diversion
Type III: Conduit necrosis; extensive Identified endoscopically Treated with conduit resection with diversion
LITERATURE SEARCH
A systematic review was carried out according to the preferred reporting items for
systematic reviews and meta-analyses (PRISMA) statement[15].  Articles indexed in
Embase  and PubMed were  searched from inception up to  January 2019,  by two
authors, using the Medical Subject Headings (MeSH) for database research and text
words related to: (esophagus OR esophageal) AND (esophagectomy) AND (conduit
necrosis OR conduit ischemia). The process of the literature search is depicted in
Figure  1.  Our  review details  the  pathophysiology,  predisposing factors,  clinical
symptoms, diagnostic approach to this problem and we will  highlight treatment
options for the management of this life threatening condition.
SEARCH RESULTS
Epidemiology
According to the literature, the incidence of conduit ischaemia or conduit necrosis
following esophagectomy varies significantly. Much of this variation could be due to
a lack of standardised definition prior to 2015. Many series report incidence of gastric
tube ischemia less than 1%[16,17]. Davis et al[16] report 0.5% gastric tube ischemia in series
of  959  esophagectomies.  Luketich  et  al [ 1 8 ]  examined  minimally  invasive
esophagectomy in a series of 1000 patients, with a 2% incidence of graft necrosis. Briel
et al[19] reported a very high rate of 10.4 % of gastric conduit ischemia in a series of 230
consecutive esophagectomy. He found no statistically significant difference between
gastric and colon interposition. A recent systematic review and meta-analysis showed
that the rate of conduit ischemia/necrosis was 0% in 13 randomized control trials and
21% in 85 observational studies[20].
Risk factors
Identifying  patients  at  risk  of  conduit  ischaemia  or  necrosis  pre-operatively  is
essential. This is to enable surgeons to consent patients to the increased risks of a poor
outcome particularly if they have several risks factors and also to try to modify these
risks prior to surgery in certain patients. Risk factors for gastric conduit ischaemia or
necrosis are shown in Table 3 and consist of a variety of patients related risks factors,
technical/surgical factors and post-operative factors[21-26].
Several  patient  related risk factors  are  associated with conduit  ischaemic  and
necrosis and these include diabetes mellitus, malnutrition, steroid use, hypertension,
cardiac arrhythmias, reduced cardiac contractility and peripheral vascular disease[19].
Lainas et al[27] reviewed 481 patients who underwent Ivor Lewis esophagectomy and
on pre-operative CT imaging assessed the degree of coeliac artery calcification and
stenosis. They found a strong association between pre-existing coeliac axis stenosis
and subsequent  conduit  necrosis[27].  Co-morbidities  including  diabetes  mellitus,
hypertension  and peripheral  arterial  disease  must  be  thoroughly  reviewed and
optimised  prior  to  surgery.  Patient  factors  such  as  smoking,  neoadjuvant
chemoradiotherapy and pre-operative weight loss were not associated with increased
ischaemia[28].
Performing a surgical resection without compromising blood supply is essential for
safe esophageal reconstruction. The blood supply to the upper abdominal viscera is
derived from the coeliac axis. Coeliac axis stenosis due to median arcuate ligament
syndrome or atherosclerosis may impair the viability of the gastric conduit used in
esophageal chest reconstruction[27]. In most cases, the conduit of choice is the stomach,
deriving its blood supply primarily from the right gastro epiploic artery[29]. Injury to
the conduit during abdominal dissection or at the time of repositioning within the
thorax  or  neck  can  be  detrimental[30].  Tension  on  the  anastomosis  or  venous
obstruction can inhibit healing at the anastomosis.  This could be due to extrinsic
compression at the thoracic inlet, and is considered to contribute to an increased rate
of failure in cervical anastomoses[30]. Extrinsic compression at the hiatus can also occur
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Table 2  Endoscopic classification system for the findings of gastric conduit ischaemia and necrosis[12]
Grades Findings
Grade 1 Dusky bluish-color mucosa around the anastomosis covered with tenacious metallatic-appearing mucous that cannot be easily washout off
Grade 2 Partial disruption of the anastomosis with equivocal viability of the adjacent mucosa or the normal pink mucosa margins
Grade 3 Complete circumferential breakdown of the anastomosis with normal pink mucosa margins
Grade 4 Completely necrotic black mucosa throughout the gastric conduit with the anastomosis still intact
due to tightness, oedema or acute diaphragmatic hernia. In addition to blood flow,
maintaining adequate tissue oxygenation to the anastomosis is vital for anastomosis
healing.
The effect of thoracic epidural analgesia on the perfusion of the gastric conduit is
controversial. The majority of units use thoracic epidural analgesia for post-operative
analgesia, especially after open trans-thoracic procedures. One small study suggested
that the epidural, perhaps due to the sympathetic block, improved blood supply to
the gastric conduit[31]. In another small study, Al-Rawi et al[32] showed by using laser
Doppler flowmetry that thoracic epidural bupivacaine decreases significantly the
arterial  blood pressure  and cardiac  output,  presumably  due  to  block  of  cardiac
sympathetics. This study has also shown that arterial pressure has a greater impact on
the tip of the gastric conduit than on the pyloric end of the gastric tube.
Ischaemic pre-conditioning
Ischaemic pre-conditioning of the gastric conduit prior to esophagectomy in order to
reduce conduit necrosis and anastomotic leak rates was first described by Urschel et
al[33]  in  1997.  Pre-conditioning  can  be  performed  radiologically  or  surgically.
Laparoscopic  ligation or  radiological  embolization of  the  left  gastric  artery,  left
gastroepiploic artery and short gastric arteries can reduce significantly the gastric
blood supply[34]. Nevertheless, the correct timing, appropriate technique and benefits
of pre-conditioning remain controversial
Gastric conduit necrosis following esophagectomy is thought to have an increased
association with minimally invasive techniques, especially in the early stages of the
learning curve. Crenshaw et al[35]  found that extracorporeal stapling of the gastric
conduit-led to a significant reduction in the incidence of gastric conduit failures when
compared with the intracorporeal stapling technique. A retrospective analysis by
Ramage et  al[36]  including 155 patients after minimally invasive esophagectomies
(MIOs),  showed  2.6%  of  conduit  necrosis.  The  authors  concluded  that  conduit
necrosis is  strongly related to the learning curve.  Prophylactic  measures such as
ischaemic preconditioning become less relevant as the operating surgeon's experience
increases.  On  the  other  hand,  tension  free  and  correct  position  of  gastric  tube,
preservation of gastroepiploic arcade without injuries and sufficient defect of the
diaphragmatic hiatus are crucial factors[36].
To try to counteract the association between gastric conduit necrosis and minimally
invasive esophagectomy, several authors have suggested that gastric ischaemic pre-
conditioning may reduce ischaemic complications. This takes the form of dividing
either the left gastric artery or short gastric vessels a week or so prior to planned
oesophagectomy. The hypothesis is that the conduit has time to get “pre-conditioned”
and reduces the risk of conduit necrosis. Berrisford et al[21], reviewed 77 consecutive
patients  who  underwent  a  total  MIO.  Their  results  suggest  that  ischaemic
conditioning of the stomach prior to MIO is safe and there is  a trend to reduced
morbidity related to gastric-conduit ischaemia[21]. Wajed et al[37] advocate laparoscopic
ischaemic conditioning by ligation of the left gastric vessels 2 weeks prior to MIO in
addition  to  extracorporeal  stapling  to  reduce  the  incidence  of  conduit  necrosis,
particularly in three stage surgery. A small randomized study by the same group did
not identify any clinical benefits with ischaemic pre-conditioning[38]. Table 4 shows the
most important studies in humans regarding gastric ischaemic pre-conditioning prior
to esophagectomy[37-43].
Intra-operative assessment of the gastric conduit
Visual intra-operative clinical assessment of the conduit perfusion is not particularly
accurate as it relies on the subjective assessment of the colour and viability of the
conduit and rate of bleeding at the anastomotic edge. Newer more modern and less
subjective  ways  to  assess  tissue  perfusion  have  been  developed to  aid  in  intra-
operative  assessment  of  gastric  conduit  viability.  These  techniques  include
fluorescence  angiography,  laser  Doppler  flowmetry  and  spectrophotometry,
transmucosal  oxygen saturation measurement,  hydrogen clearance,  visible  light
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Figure 1
Figure 1  Schematic diagram of procedural methodology.
spectroscopy, intra-operative endoscopy, and laser-induced fluorescence of indoc-
yanine green (ICG)[44-57].
The most common intra-operative devices used are Doppler ultrasound and ICG
fluorescence imaging, mainly because they provide adequate visualization of the
vessel networks of the gastric wall[47-56]. ICG fluorescence imaging is considered to be a
potential technique for higher sensitivity, especially after the encouraging results in
different tumours, mainly in colorectal and liver cancer[58]. Table 5 illustrates the most
important studies of ICG fluorescence imaging in esophageal cancer[47-56]. The vast
majority of the published articles conclude that ICG fluorescence is useful for the
prediction of the risk of anastomotic leak and also can be used for intraoperative
modifications with better placement of the anastomosis and resection of the ischaemic
area of the fundus[47-56]. A randomised trial in this area specifically assessing the use of
ICG assessment during esophagectomy is greatly required.
MANAGEMENT OPTIONS
Intra-operative conduit ischaemia
Acute intraoperative conduit ischaemic is a challenging scenario for esophagogastric
surgeons.  Should the conduit  look hypo-perfused due to inadequate blood flow,
recognising it in a timely fashion is essential if the conduit is to be saved. The hiatus
should be checked to ensure it is not too tight and there is no impingement on the
gastroepiploic vessels. Additionally, the gastric conduit should be checked to ensure it
is not twisted. If the situation develops during the neck phase of the procedure, then
the thoracic inlet should be checked for tightness. This can be released to some extent
by resection of the sternal head and the manubrium; which is mandatory should the
graft be positioned at this level substernally. If there is any doubt as to the viability of
the conduit, anastomosis should not be performed. If it looks like the gastric conduit
is unsalvageable then it should be resected and a cervical esophagostomy formed,
with subsequent plans for a delayed reconstruction instituted. Delayed reconstruction
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Table 3  Risk factors for gastric conduit necrosis
Patient factors Technical Factors Post-operative factors
Peripheral arterial disease Twists in the gastric conduit Post-operative hypotension and shock
Ischaemic heart disease Tight hiatus Vasoconstrictor use
Stenosis of the Coeliac trunk and Aorta[27] Injury to the gastro-epiploic vessels
Cardiac failure/ impaired ejection fraction Minimal access procedures[21]
Diabetes Tacking sutures to the pre-vertebral fascia during
transhiatal esophagectomy[22]
Tight thoracic inlet when a neck anastomosis is
performed
Narrow gastric conduit
can be performed with colon or small bowel, depending on the clinical situation.
Oezcelik et al[59] published a series of 554 patients who underwent esophagectomy
with gastric pullup and described an interesting strategy. In 37 patients (7%), the
combination of an ischemic graft and substantial comorbid conditions prompted a
delayed neck anastomosis. To avoid a high risk anastomosis in these patients, the
gastric  conduit  was  brought  up  and  secured  in  the  neck,  and  a  cervical
esophagostomy  was  constructed.  Subsequently,  a  delayed  esophagogastric
anastomosis was performed through neck incision. Outcomes were analysed at a
median of 22 mo. None of the patients has developed conduit ischemia or necrosis.
The authors reported well-perfused conduits at the time of reconstruction without
anastomotic leak, sepsis or wound infections post-operatively. They concluded that
delayed  reconstruction  is  strongly  recommended  for  patients  with  significant
comorbidities and for patients with inadequate blood supply of the conduit during
the esophagectomy[59].
Post-operative conduit ischaemia /necrosis
Patients with mild ischaemic changes with a small anastomotic leak may be managed
successfully with an esophageal stent, naso-gastric drainage and enteral feeding[60].
Liang et al[61] reported two patients who were salvaged using a temporary removable
self-expandable metal stent (SEMS) placed endoscopically and concomitant chest
washout. However, both patients had type II conduit necrosis which is most likely to
have successful outcome using SEMS. The aforementioned management is considered
to be effective only in a very cautiously selected patients and it is recommended only
if there is minor gastric conduit necrosis, without inflammation of the mediastinum
and if the patient remains clinically stable. Patients without an associated anastomotic
leak should be closely monitored.
In  selected  cases  with  minor  areas  of  peri-anastomotic  ischaemia  or  conduit
necrosis  in  a  stable  patient  with no major  comorbidity,  the  anastomosis  may be
suitable for re-fashioning or repaired over a T-tube. If this is not the case, it is safer to
completely take down the anastomosis at the second thoracotomy with debridement
of  necrotic  tissue,  wide  drainage,  proximal  diversion  with  an  end  cervical
esophagostomy  and  replacement  of  remaining  stomach  within  the  abdomen[3].
Nutritional  access with a feeding jejunostomy should be obtained if  this  has not
already been achieved.
Delayed reconstruction after conduit necrosis
Reconstruction can be performed in a  few ways following the take down of  the
necrotic conduit.
Colonic reconstruction
Esophageal replacement by colonic interposition is an uncommon procedure. These
reconstructions can be pedicled or free grafts  with or without venous or arterial
supercharging.  When the  colon is  used as  the  conduit,  graft  necrosis  after  neck
anastomosis has been reported as high as 16%[62]. This is likely exacerbated by colonic
bacterial  contamination,  particularly if  the patient has not been prepped. This is
usually fatal if not recognised and treated early. Fisher et al[63] sought to identify the
frequency of this operation in England, identify techniques and associated problems
from the two largest centres performing this procedure. Fifty-two percent preferred to
use the left colon with 81% preferring a substernal placement. All patients had early
satiety, 20 described dysphagia and 18 regularly took anti-reflux medication. Colon
interposition results in an acceptable long-term health-related quality of life. Few
WJGS https://www.wjgnet.com March 27, 2019 Volume 11 Issue 3
Athanasiou A et al. Conduit necrosis following esophagectomy
161
Table 4  Published Series of gastric ischaemic pre-conditioning prior to oesophagectomy in humans
Ref. Country Study design Patient (n) Days prior toresection Technique Results
Akiyama et al[39],
1998
Japan Retrospective 51 14 Preoperative
embolization of left
gastric, right gastric,
and splenic artery
PET is a safe
procedure that
contributes to the
decrease in the
frequency of
anastomotic
dehiscence after
esophageal
operation
Isomura et al[43], 1999 Japan Retrospective 37 14 Preoperative
embolization of left
gastric, right gastric,
and splenic artery
Reduction of
postoperative
anastomotic leakage
in esophageal
reconstruction
Nguyen et al[40], 2006 United States Retrospective 9 12 ± 10 Ligation of left
gastric vessels
There were no
anastomotic leaks in
the 9 patients
Veeramootoo et
al[38], 2012
United Kingdom Randomized
controlled trial
16 14 Ligation of left
gastric vessels
Laparoscopic
ischemic
conditioning does
not translate into an
improved perfusion
of the gastric
conduit tip
Wajed et al[37], 2012 United Kingdom Retrospective 67 14 Ligation of left
gastric vessels
9 of them (13.4%)
developed gastric
conduit failure
Bludau et al[42], 2010 Germany Prospective 19 4-5 Ligation of short
gastric arteries and
left gastric artery
Ischemic
conditioning
improves Mucosal
oxygen saturation in
the anastomotic
region at the time of
reconstruction
Holscher et al[41],
2007
Germany Retrospective 83 3-7 Laparoscopic gastric
devascularisation
preserving right
gastroepiploic
arcade
Feasible and safe
technique that may
contribute to the
reduction of
postoperative
morbidity and
mortality after
esophagectomy
PET: Pre-operative embolization therapy.
centres regularly perform this operation, and centralizing to high-volume centres may
lead to better outcomes[63]. Supercharged colon interposition is an alternative surgical
technique for the reduction of  ischemic related morbidity[64,65].  In addition to the
abdominal blood supply, the venous drainage and arterial supply is augmented with
additional microvascular anastomoses in the neck (branches of the carotid artery or
jugular veins depending on anatomy). Small series have showed low rates of leak,
bowel ischaemia and graft loss. In a retrospective series by Fujita and co-workers[64], 24
patients underwent reconstruction without supercharged colon interposition and
were  compared with  29  patients  with  supercharged colon.  The  vast  majority  of
patients underwent thoracic esophagectomy. The results revealed that the group who
received supercharged colon had a significantly lower rate of conduit necrosis and
anastomotic leak. These techniques require the skills of a microvascular surgeon.
According to the literature, colon interposition due to gastric conduit necrosis is
recommended only after esophageal diversion and delayed neck reconstruction[66,67].
Esophageal  diversion  is  considered  to  be  a  staged damage-control  operation  in
combination with mediastinal drainage, nutritional supplementation via a feeding
jejunostomy and antimicrobial therapy.
Jejunal reconstruction
Jejunal interposition with or without vascular supercharging is an alternative option
for esophageal reconstruction[68].  Advantages of this technique include the lack of
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Table 5  Clinical studies for the evaluation of ischemic gastric conditioning using indocyanine green fluorescence imaging
Ref. Year Patient (n) Imaging system Dose ofICG Study design Conclusions
Kitagawa et al[47] 2017 72 PDE 2.5 mg Retrospective Intraoperative ICG
assessment of the
gastric tube was
associated with
postoperative
endoscopic
assessment grading
of anastomosis
during ER
Ohi et al[51] 2017 120 PDE 2.5 mg Retrospective ICG fluorescein
imaging might
decrease the
incidence of
anastomotic leak
following ER
Koyanagi et al[48] 2016 40 PDE 2.5 or 1.25 mg Prospective cohort ICG fluorescence is a
useful means to
predict the risk of
anastomotic leakage
after ER
Yukaya et al[55] 2015 27 Hyper Eye Medical
System
0.1 mg Prospective cohort ICG fluorescence
can be used to
quantitatively
measure arterial
blood flow and
venous return of the
reconstructed gastric
tube in patients
undergoing ER
Zehetner et al[56] 2015 150 SPY Imaging System
(Novadaq)
2.5 mg Prospective cohort The use of laser-
assisted fluorescent-
dye angiography
(LAA) may
contribute to
reduced anastomotic
morbidity
Sarkariaet al[53] 2014 30 NIFI technology 10 mg Prospective cohort ICG fluorescence
may be a useful
adjunct during MIE
gastric mobilization,
especially early in
the learning curve
for these operations
Rino et al[52] 2014 33 PDE 2.5 mg Prospective cohort ICG fluorescence
can be used to
evaluate the blood
supply to the
reconstructed
stomach in patients
undergoing ER for
esophageal cancer
Kumagai et al[49] 2014 20 PDE NA Prospective cohort ICG fluorescence
method has
potential usefulness
for evaluation of
blood flow in the
gastric tube during
ER
Pachecoet al[46] 2013 11 SPY Imaging System
(Novadaq)
NA Retrospective ICG fluorescence
might be useful in
patients undergoing
ER
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Murawaet al[50] 2012 15 PDE 2.5 mg Prospective cohort ICG fluorescence
imaging allows for
intraoperative
modifications, but
patient’s
comorbidities and
general health may
also increase the risk
of anastomosis
leakage
Shimad et al[54] 2011 40 PDE 2.5 mg Prospective cohort The microcirculation
detected by ICG
fluorescence did not
necessarily provide
appropriate blood
supply for a viable
anastomosis
ICG: Indocyanine green; ER: Esophageal resection; PDE: Hamamatsu Photonics K.K, Hamamatsu, Japan.
need for pre-operative bowel preparation, it is relatively easy to mobilise, sizable
mesenteric blood vessels, comparable size to esophagus, bowel anastomoses with low
leak rates and active peristalsis.  Disadvantages included that it  is  a rare form of
esophageal replacement and only a few centres have experience of its use. Depending
on circumstances its use will usually require the help of a micro-vascular surgeon to
either supercharge or free graft the blood supply in the neck vessels. Augmentation of
pedicle blood supply increases the length of conduit and restores more blood flow,
which allows a neck anastomosis of the jejunum to be performed in the left neck[69].
Ascioti et al[68], reviewed retrospectively 26 patients who underwent reconstruction
with supercharged pedicled jejunum and found a 19.2% had cervical anastomotic
leak,  7.7%  of  graft  loss  and  there  were  no  mortalities.  All  patients  underwent
oesophageal  reconstruction  with  a  neck  anastomosis.  Use  of  jejunum is  contra-
indicated in Crohn’s disease, short bowel syndrome and short fatty mesentery. Jejunal
conduit necrosis is usually due to technical errors,  poor vascular supply, venous
thrombosis and perioperative hypotension[70].  According to the literature,  jejunal
interposition after gastric or colon conduit necrosis is indicated only after esophageal
diversion and delayed neck reconstruction[64,65].
Myocutaneous flap reconstruction
An alternative method for the management of conduit necrosis using muscle flaps has
been proposed in the literature. These are more applicable for dealing with partial
defects in the gastric conduit in the neck, but can be used in selected cases for salvage
of completely circumferential defects. Myocutaneous flap is utilized usually in order
to  reconstruct  gastric  conduit  defect  due to  conduit  necrosis  as  well  as  to  cover
anastomotic defect. However, is not recommended for complete oesophageal neck
reconstruction by formation of tube-style tissue due to high rate of complications
including  stenosis  and  necrosis[71].  Sternocleidomastoid,  pectoralis  major  and
trapezius flaps have all been reported to cover tissue defects in the neck. However,
much  of  the  published  literature  is  from  individual  case  reports.  Furthermore,
fasciocutaneous free flaps, for example anterolateral thigh and radial forearm have
also been reported which can replace the oesophagus in the neck area with the skin
side  tubularised.  A single  pedicled pectoralis  major  myocutaneous  for  cervical-
oesophageal reconstruction is the most commonly used flap due to the fact that there
is no need for free tissue transfer and also because it is easier to harvest the muscle
due to its location to the chest[72]. This flap has a lower rate of flap failure compared
with free flaps for cervical-oesophageal reconstruction[73].
Morbidity and mortality
Mortality  of  gastric  conduit  necrosis  has  been  reported  to  be  as  high  as  90%[4].
Esophageal  conduit  necrosis  is  an  uncommon  but  disastrous  complication  of
esophageal  surgery.  Postoperative  conduit  ischemia  is  reported  internationally.
Average rates of ischemic complications for stomach, colon, and jejunum are 3.2%,
5.1%, and 4.2%, respectively[4].
Davis et al[16] showed that gastric conduit reconstruction has less rate of anastomotic
leak and conduit ischemia in compare with colon reconstruction. Moorehead et al[17], in
their review of 760 esophagectomy patients in whom the stomach, colon, or jejunum
was used for chest or neck reconstruction, showed that gastric conduit had the lowest
rate of ischemia (1%), followed by small bowel (11%), while colon had the highest rate
(13.3%). Moreover, Briel et al[19] compared colon and gastric conduit after two or three
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stage esophagectomy and they reported 10% colon conduit ischemia and 7% gastric
conduit ischemia.
CONCLUSION
In spite of recent advances in esophageal cancer surgery, the management of conduit
necrosis  is  extremely  challenging.  Management  options  include  conservative
treatment  and  more  aggressive  treatments  such  as  stent  insertion,  surgical
debridement  and  repair  of  the  esophagus  using  je junum,  colon  or  a
musculocutaneous flap. Conservative management includes close clinical monitoring
of patient symptoms and signs including heart rate, blood pressure, temperature,
respiratory  rate  and  oxygen  saturations  in  addition  to  blood  results  and  the
administration  of  broad  spectrum  antibiotics.  Identifying  and  acting  upon  any
deterioration is vital. While there are several interventional options, deciding upon
the  most  appropriate  for  each  individual  patient,  is  challenging  for  the  most
experienced surgeon. All interventional options are high risk. The most effective
treatment method remains controversial.
The literature available for review is limited and so surgeons should endeavour to
report  all  cases of  esophageal  necrosis,  their  management whether successful  or
unsuccessful. Several multi-institutional databases are in current use. For example,
Esodata  (https://www.esodata.org)  under  the  auspices  of  ISDE -  International
Society for the Diseases of Esophagus - have developed a web portal for creating and
sharing  expert  views  and  current  knowledge  on  complications  and  outcomes
esophageal  surgery.  In  addition,  the  oesophagogastric  anastomotic  leak  audit
(http://www.ogaa.org.uk/) aims to collect data of anastomotic complications from
esophagectomy,  including conduit  necrosis,  from a  large  group of  international
esophageal units to define the accurate incidence and outcome of this problem. It is
only with prospective and standardised data from these multi-centre registries that
we can help address the void of high quality literature of this important topic. It is
hoped that once we have standardised data of many patients with this devastating
condition, that the precise management strategy to obtain best outcomes will become
clear.
As  with  most  complex  surgical  procedures,  high  volume  surgeons  and  high
volume centres have significantly higher success rates with esophageal resections[74,75].
Knowledge of the potential complications, identifying them in a timely fashion and
managing them appropriately is essential. The management of this problem should be
individualised to the specific patient depending on severity of ischaemia and clinical
features. The description in 1942 by Churchill and Sweet[76] of their early successes
with esophago-enteric anastomoses due to “unusual attention to detail” and technical
“exactitude” remain a  cornerstone for  future  advances  by surgeons  involved in
esophageal resection and replacement.
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